Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Human Longevity
MedTech
Human Longevity seeks new life with proposed SPAC deal
Human Longevity, which aims to help people live past age 100, inked a blank-check company deal to grab a spot on the NYSE and collect $345 million.
Conor Hale
Jun 21, 2022 12:57pm
Cambrian snags $100M for 14 assets, 3-5 trials within 18 months
Oct 26, 2021 7:05am
Human Longevity accuses J. Craig Venter of stealing secrets
Jul 23, 2018 6:30am
Chutes & Ladders—Human Longevity CFO/COO departs after scandal
Jul 20, 2018 8:30am
After scandal, Human Longevity lets CFO/COO go
Jul 13, 2018 8:35am
Juvenescence bags $50M to advance anti-aging projects
Jun 11, 2018 3:06pm
